Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome

BackgroundPolycystic ovarian syndrome (PCOS) is one of most common endocrine disturbances in women of reproductive age. Besides its well known effects on reproductive health, it is also linked to increased cardiovascular risk in later life.ObjectivesThe aim of this study was to investigate the link between some anthropometric indices of visceral obesity and surrogate markers of cardiovascular risk according to the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society consensus.Study designThe study included 36 normal weight (BMI < 25 kg/m2) and 19 obese PCOS subjects (BMI ≥ 30 kg/m2), aged between 18 and 40 years. Different anthropometric markers were compared as predictors for an adverse cardiometabolic profile and composite cardiovascular risk factors as defined by the AE-PCOS consensus.ResultsBoth waist-to-stature ratio (WSR) (area under the curve 0.75, p = 0.002) and waist circumference (WC) (area under the curve 0.77, p = 0.001) but not waist-to-hip ratio (WHR) (area under the curve 0.62, p = 0.143) were shown to be good markers of increased cardiovascular risk, insulin resistance and dislipidemia in PCOS patients. The cut-off point for WSR of 0.50 is useful and the cut-off of 80 cm for WC is more appropriate than 88 cm in detecting cardiovascular risk in PCOS patients. Androgen levels and immunoreactive insulin during an oral glucose tolerance test had lower power for predicting increased cardiovascular risk than WC and WSR.ConclusionThe study indicates that WSR and WC are better associated with composite cardiovascular risk factors as defined by the AE-PCOS consensus than WHR, and that the commonly used cut-off for WSR of 0.5 is useful for detecting cardiovascular risk in PCOS patients.